<p class="MsoNormal">The efforts to develop a vaccine hit snags, with Johnson & Johnson pausing its trial after an unexplained illness in a participant while AstraZeneca’s US trial still on hold, more than a month after the firm announced the suspension of the Phase 3 trial due to safety concerns.</p>
